Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Natalie Gauld

Natalie Gauld

Dr Natalie Gauld is a pharmacist and reclassification consultant at Natalie Gauld Ltd. She is an Honorary Research Fellow at the Department of General Practice and Primary Health Care, University of Auckland, New Zealand. She has received funding for reclassifications including trimethoprim, vaccinations, calcipotriol, adapalene, sildenafil and oral contraceptives. She was on the Medicines Classification Committee in NZ (2004-2009). She has consulted to Green Cross Health, the pharmaceutical industry and pharmacy organisations. She has received travel funding for speaking engagements at conferences from industry and pharmacy organisations. She received unrestricted research grants from Green Cross Health, the Pharmacy Guild, the Pharmaceutical Society of NZ and ProPharma for the trimethoprim research. She is a member of the National Executive of the Pharmaceutical Society of NZ. The opinions expressed in this article are the author’s, and not as a representative of any organisation.

Recent stories

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.